Chapter 01 · The criteria
Who the criteria are written for
GLP-1 medications approved for chronic weight management are indicated, alongside a reduced-calorie diet and increased physical activity, for adults with a body mass index of 30 or higher, or 27 or higher when a weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol is also present.1 This self-screen reflects those BMI-based criteria; it is not an approval and not a diagnosis.
*12 month plan, billed once for the term when a physician approves. Renews each term.
BMI is a rough screening number, not the whole picture. It does not account for muscle, body composition, or where weight is carried, so a clinician interprets it alongside your waist measurement, your history, and your goals rather than treating the number alone.
Chapter 02 · How it works
What a GLP-1 medication is, and who decides
GLP-1 (glucagon-like peptide-1) is a hormone the body makes that helps regulate appetite and blood sugar; these medications are synthetic versions used as one part of a plan that includes nutrition and activity. To be clear about who does what: sipra connects you with US-licensed physicians who decide whether a medication is appropriate for you. We are not the compounder, and compounded medications are not FDA-approved and are not equivalent to the brand-name products. A licensed physician makes the final decision after reviewing your history. Individual results vary.
Start here · one question
What's your goal weight?
Choose a goal to discuss with your clinician. You can change it in your intake.
Some people should not take these medications, or need extra caution, including those with a personal or family history of medullary thyroid cancer or MEN2, those who are pregnant or planning pregnancy, and those with certain other conditions. GLP-1 medications are not recommended for weight loss during pregnancy. Available human data have not shown a clear increase in major congenital malformations after inadvertent early-pregnancy exposure, so an unexpected exposure is a reason to contact a clinician, not to assume harm. Breastfeeding decisions also require individual clinical review.3 This is why the screen routes anyone with those flags to a clinician first, regardless of BMI.
Chapter 03 · The fine print
What this self-screen does not do
This tool does not approve you for any medication, diagnose any condition, or guarantee that a physician will prescribe treatment. It mirrors the published BMI-based criteria so you can see roughly where you stand before a visit. Eligibility, safety, and the choice of any treatment are clinical decisions a licensed physician makes after reviewing your full history. Individual results vary.
Meeting the criteria is not the same as being approved. A licensed physician reviews your history, weighs risks and benefits, and makes the final decision.
